Navigation Links
At long last, scientists figure out how plants grow

It has been one of the great mysteries in plant science.

Scientists have known since 1885 that the plant growth hormone auxin exists. They've known of its dramatic effects on plant growth and development since the 1930s. But only now do scientists know how it works.

In this week's Nature, Indiana University Bloomington biologists Mark Estelle, Nihal Dharmasiri and Sunethra Dharmasiri identify TIR1 as the protein that, with auxin, influences how and when plant cells grow and divide. In the same issue, scientists in the United Kingdom report a virtually identical result.

"How auxin works has been a holy grail in plant science," said Estelle, who led the research. "This was something even Charles Darwin considered, if only in spirit. That we've all been trying to figure it out for so long makes this latest discovery very satisfying."

Estelle said the finding is important for basic plant science, but may also lead to new insight into how related proteins function in animals, including humans.

In a 2001 report (also in Nature), Estelle and colleagues showed that the protein TIR1 acts to increase the expression of certain growth-related genes.

The scientists had not known at the time that TIR1 interacts directly with auxin (also known as indoleacetic acid, or IAA). With that finding, the scientists can now envision a complete life history for the growth hormone. Auxin is produced in the tips of plant shoots and branches. The hormone travels downward toward the roots. It migrates into plant cell nuclei, where it is picked up by the TIR1 portion of a four-protein complex called SCF(TIR1). SCF(TIR1) and auxin binds to yet another protein that represses the expression of a particular set of genes. And it's this complex of auxin, SCF(TIR1) and the repressor that signals enzymes to destroy the repressor, thereby turning on the repressed gene.

"The key interaction is between TIR1 and the repressor," Estelle said. "Nihal was
'"/>

Source:Indiana University


Page: 1 2

Related biology news :

1. Wisconsin scientists grow critical nerve cells
2. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
3. UAB scientists discover the origin of a mysterious physical force
4. Fox Chase Cancer Center scientists identify immune-system mutation
5. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
6. U-M scientists find genes that control growth of common skin cancer
7. UCLA scientists transform HIV into cancer-seeking missile
8. RNA project to create language for scientists worldwide
9. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
10. To control germs, scientists deploy tiny agents provocateurs
11. Leprosy microbes lead scientists to immune discovery

Post Your Comments:
(Date:11/23/2009)...niversity of Alabama at Birmingham (UAB) researche...g medical conditions (co-morbidity) do not explain...ricans compared to Caucasians who also have colon ...Cancer , a journal of the American Cancer Society....o-morbidity are independent predictors of poor sur...
(Date:11/23/2009)...l in unprecedented detail how the ribosome interac...nd guide them toward their destination in biologic...ible fitting (MDFF) to examine the interaction of .... , The first study, in Proceedings of the Nat...signaling between the ribosome and an elongation f...
(Date:11/23/2009)...scoveries about the multiple health benefits of vi... nutrient, increased awareness of the huge numbers...ch and even led to an appreciation of it as "natur...alth of your immune system to prevention of heart ...in D is now seen as one of the most critical nutri...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3Helix BioPharma to Present L DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 12711 1Helix BioPharma to Present L DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 12711 2Helix BioPharma to Present L DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 12711 3Helix BioPharma to Present L DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 12711 4Helix BioPharma to Present L DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 12711 5Chemicals in Marijuana Smoke May Harm DNA 49526 1Synutra Annual Report on Form 10 K Includes Going Concern Explanatory Paragraph from Auditor 49524 1Synutra Annual Report on Form 10 K Includes Going Concern Explanatory Paragraph from Auditor 49524 2
... expanding into new territory, successfully aiding...valves in patients too sick to withstand open-ches...th Annual Scientific Sessions of the Society for C..., May 9?2, 2007, in Orlando, FL, patients who were...Valve, Irvine, CA) experienced improvements in bot...
...e use of tissue-engineered scaffolding made of car... naturally, to replace defective cartilage tissue....caffold which is implanted into the body, where ne...he study appears in the journal Artificial Organs....d mice as the study found these scaffolds to be a ...
...e-dose anticlotting medication just before percuta...d risk of heart attack and cardiac death by half, ...cientific Sessions of the Society for Cardiovascul...2007, in Orlando, FL. , Researchers found that gi...e stenting, rather than the standard 300-mg dose, ...
Other Biology News:Percutaneous aortic valve replacement safe, successful in high-risk patients 2High-dose anticlotting drug cuts heart attack, death risk in half 2
(Date:11/20/2009)...ecently announced that Dr. Dominique Hebrault will...s Analytical Technology (PAT) in Green Chemistry a..., (PRWEB) November 20, 200...chnology (PAT) in Green Chemistry and Green Engine...echnology (PAT) case studies will be presented on ...
(Date:11/19/2009)...rstCall/ -- Omeros Corporation (Nasdaq: OMER ) to...third quarter ended September 30, 2009. For the th...ed a net loss of $3.9 million, or $1.34 per share,...54 per share, for the same period in 2008. For the... reported a net loss of $15.5 million, or $5.29 pe...
(Date:11/19/2009)...irstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), ann... to its shareholders, discussing the Company,s acq...euticals Holdings, Inc. (CHBP), an integrated bio-...lic of China. The merger gives NeoStem a controlli...Ltd., CHBP,s primary operating subsidiary and a pr...
(Date:11/19/2009)...er 19 MONITORING FORCE GmbH,announ...ibanserin in the,indication treatment-relevant lev...r orphan drug status designation with the European...sia is a complication of the mainstay,treatment in... of those,affected, since it may be disabling for ...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
... 16 ,Boston Scientific Corporation (NYSE: BSX ) a...the signing of a definitive merger agreement, unde... price of $1.35 per share of,CryoCor, or approxima...elopment agreement, in place since June 2007, to p...n, or "Afib." Afib is the most common,cardiac arrh...
... Inc.,announced today that it has closed the secon...cing. As previously announced, Aisling Capital led...ew investors, the D.E. Shaw,group and Boston Life ...omura Phase4 Ventures, Novartis BioVentures, BioFu... Hentsch, BioVeda Fund and Hercules,Technology Gro...
... Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, ...er and his research group at St. James,s Universit...their work in the April 10 online issue of,Gene Th...Cell Killing by,Oncolytic Reovirus for the Treatme...eovirus effectively kills and replicates,in both h...
Other Biology Technology:Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 2Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 3Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 4Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 5Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 6Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections 2Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections 3Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma 2
...RS are multi-functional mixing devices. Stepping m... solid, heavy-duty durable shaker to provide a uni...ature. Regulated action scale for all modes. Micro...trol time, continuous time, action scale and speed...
Finnigan LTQ FT from Thermo Scientific
PDQuest 10-User Network License from Bio-Rad
Mouse Anti-Human JRKL Monoclonal Antibody, Unconjugated, Clone 4E10 from Abnova Corporation
Biology Products: